This afternoon we watched Bath & Body Works rise 6.8% to a price of $31.75 per share. The mid-cap Specialty Retail company is now trading -29.62% below its average target price of $45.11. Analysts have set target prices ranging from $27.0 to $68.0 per share for Bath & Body Works, and have given the stock an average rating of buy.
Bath & Body Works's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 5.0%. The stock's short ratio is 3.19. Only 0.46% of the company's shares are owned by insiders, indicating that management does not have a deep alignment of interest with its shareholders.
Another number to watch is the company's rate of institutional share ownership, which now stands at 93.8%. In conclusion, we believe there is mixed market sentiment regarding Bath & Body Works.
Institutions Invested in Bath & Body Works
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-06-30 | Vanguard Group Inc | 11% | 25,621,623 | $813,486,530 |
| 2023-06-30 | Lone Pine Capital Llc | 7% | 16,356,915 | $519,332,051 |
| 2023-09-30 | Blackrock Inc. | 7% | 16,258,320 | $516,201,660 |
| 2023-06-30 | Third Point, LLC | 6% | 13,850,000 | $439,737,500 |
| 2023-06-30 | T. Rowe Price Investment Management, Inc. | 5% | 11,745,372 | $372,915,561 |
| 2023-06-30 | State Street Corporation | 4% | 9,782,690 | $310,600,407 |
| 2023-06-30 | Price (T.Rowe) Associates Inc | 4% | 8,383,184 | $266,166,092 |
| 2023-06-30 | Atreides Management, LP | 2% | 5,641,028 | $179,102,639 |
| 2023-06-30 | JP Morgan Chase & Company | 2% | 5,619,748 | $178,426,999 |
| 2023-09-30 | Primecap Management Company | 2% | 5,618,075 | $178,373,881 |
